400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
2023-03-07
细胞免疫治疗法研发商
医药研发/制造
化学&生物药
4BIO Capital;
4BIO Capital;
Solasta Ventures;
Solasta Ventures;
Penn Medicine;
TPG Biotech;
M Ventures;
MRL Ventures Fund;
Agent Capital;
Pictet Alternative Advisors;
Livzon International Ventures;
Symbiosis Group;
HealthCap;
Wellington Partners;
AbbVie Biotech Ventures
中国农药工业协会2026-01-26
经纬创投2026-01-26
GMP办公室2026-01-26
功能与专用化学品2026-01-26
一度医药2026-01-26
细胞与基因治疗领域2026-01-26
同写意2026-01-26
CIO合规保证组织2026-01-26
德联资本2026-01-26
生物安全情报网2026-01-26